Abingdon Health is a UK based medical diagnostics group focused on developing, manufacturing and commercialising point of care immunoassay tests for disorders of the immune system.

Our initial focus is on developing rapid tests for hematology oncology and specifically B cell dyscrasias.

We launched our first rapid testing product in this market in March 2015, Seralite®– FLC, the world’s first rapid diagnostic device in multiple myeloma.